Summary
As part of its participation in VivaTech 2022, the European event dedicated to technological innovation, CNRS is presenting a sample of its deeptech know-how through various start-ups from its laboratories.
Among them, Damae Medical is reinventing medical imaging. Its deepLive™ solution enables accurate, fast and reliable non-invasive optical skin examination in the screening and monitoring of skin cancers.
As for Genoskin, its technology is designed to provide the pharmaceutical and cosmetic industry with better study platforms to generate more reliable data and reduce the risk of clinical trial failure. Its HypoSkin® model provides human data upstream of clinical trials and produces ex vivo models of human skin and maintains its structural and functional properties.
Among them, Damae Medical is reinventing medical imaging. Its deepLive™ solution enables accurate, fast and reliable non-invasive optical skin examination in the screening and monitoring of skin cancers.
As for Genoskin, its technology is designed to provide the pharmaceutical and cosmetic industry with better study platforms to generate more reliable data and reduce the risk of clinical trial failure. Its HypoSkin® model provides human data upstream of clinical trials and produces ex vivo models of human skin and maintains its structural and functional properties.
